| Baseline | After 8–10# CRT | % Change | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient | pTRG | Stage | Clinical | Tumour | Muscle | T:M | Tumour | Tumour | % of | Tumour | Muscle | T:M | Tumour | Tumour | % of | Tumour | Muscle | T:M | Tumour | Tumour | % of |
Number | AJCC | Â | Response | SUV | SUV | SUV | hypoxic | ROI | tumour | SUV | SUV | SUV | hypoxic | ROI | tumour | SUV | SUV | SUV | hypoxic | ROI | tumour |
 |  |  |  | max | max | max | volume | volume | volume | max | max | max | volume | volume | volume | max | max | max | volume | volume | volume |
 |  |  |  |  |  |  | cm3 | cm3 | i.e. hypoxic |  |  |  | cm3 | cm3 | i.e. hypoxic |  |  |  |  |  | i.e. hypoxic |
P1 | 1 | ypT3N2 | Poor | 2.09 | 1.54 | 1.35 | 0.05 | 80.41 | 0.06 | 1.79 | 1.32 | 1.36 | 0.15 | 88.60 | 0.17 | −14.35 | −14.50 | 0.17 | 199.99 | 10.19 | 172.26 |
P2 | 1 | ypT3N1 | Good | 5.19 | 2.30 | 2.26 | 1.93 | 23.20 | 8.32 | 4.97 | 1.73 | 2.87 | 2.93 | 26.85 | 10.93 | −4.31 | −24.68 | 27.05 | 51.90 | 15.70 | 31.28 |
P3 | 3 | ypT3N0 | Poor | 3.39 | 1.95 | 1.74 | 0.98 | 179.77 | 0.54 | 2.24 | 1.93 | 1.16 | 0.00 | 86.53 | 0.00 | −33.86 | −1.00 | −33.19 | −100.00 | −51.87 | −100.00 |
P4 | 2 | ypT3N0 | Poor | 4.16 | 1.74 | 2.39 | 4.03 | 30.66 | 13.16 | 2.70 | 1.84 | 1.47 | 0.20 | 13.35 | 1.47 | −35.10 | 5.79 | −38.65 | −95.15 | −56.46 | −88.86 |
P5 | NR | N/A | Good | 4.98 | 1.93 | 2.58 | 3.18 | 62.59 | 5.08 | 1.78 | 1.68 | 1.06 | 0.00 | 55.79 | 0.00 | −64.17 | −12.69 | −58.96 | −100.00 | −10.86 | −100.00 |
P6 | NR | N/A | Poor | 3.38 | 2.03 | 1.66 | 0.81 | 18.80 | 4.29 | - | - | - | - | - | - | - | - | - | - | - | - |
P7 | NR | N/A | Good | 3.52 | 1.62 | 2.17 | 0.39 | 4.16 | 9.41 | 2.44 | 1.51 | 1.62 | 0.12 | 0.93 | 13.16 | −30.54 | −6.85 | −25.43 | −68.75 | −77.65 | 39.80 |
P8 | 2 | ypT3N2 | Poor | 5.31 | 2.35 | 2.27 | 1.17 | 28.43 | 4.13 | 2.49 | 1.95 | 1.27 | 0.00 | 28.61 | 0.00 | −53.22 | −16.71 | −43.84 | −100.00 | 0.60 | −100.00 |
P9 | 2 | ypT3N1 | Poor | 3.04 | 1.45 | 2.10 | 1.44 | 15.06 | 9.58 | 1.82 | 1.41 | 1.30 | 0.00 | 13.96 | 0.00 | −39.97 | −2.59 | −38.37 | −100.00 | −7.31 | −100.00 |
P10 | 0 | ypT0N1 | Good | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
P11 | 2 | ypT3N0 | Good* | 1.94 | 1.74 | 1.11 | 0.00 | 10.98 | 0.00 | 2.40 | 1.88 | 1.27 | 0.00 | 5.23 | 0.00 | 23.87 | 8.16 | 14.52 | 0.00 | −52.34 | 0.00 |
Median |  |  |  | 3.46 | 1.83 | 2.14 | 1.08 | 25.82 | 4.68 | 2.40 | 1.73 | 1.30 | 0.00 | 26.85 | 0.00 | −33.86 | −6.85 | −33.19 | −95.15 | −10.86 | −88.86 |
IQR | Â | Â | Â | 1.65 | 0.36 | 0.58 | 1.31 | 38.61 | 7.70 | 0.66 | 0.37 | 0.19 | 0.15 | 42.44 | 1.47 | 25.62 | 13.49 | 38.81 | 100.00 | 52.94 | 131.28 |